The Biomarker Discovery Outsourcing Services Market is witnessing significant transformation, shaped by innovation, evolving consumer expectations, regulatory shifts, and global economic trends. Polaris Market Research’s latest report, Biomarker Discovery Outsourcing Services Market, offers a holistic view of the market. It examines the market’s structure, growth drivers,...

The global companion animal diagnostics market is witnessing strong momentum as pet healthcare becomes an increasingly important priority for owners worldwide. Growing awareness of preventive veterinary care, rising pet adoption, and continuous innovations in diagnostic technologies are encouraging veterinarians to adopt advanced testing solutions for faster and more accurate disease...

The increasing adoption of targeted therapies and precision healthcare approaches is transforming the diagnostics landscape through advanced biomarker testing, personalized medicine diagnostics, and innovative oncology companion diagnostics. As healthcare shifts from generalized treatment approaches toward patient-specific therapies, companion diagnostics are becoming essential tools for...

Companion Diagnostics Oncology Market to Reach USD 12.31 Billion by 2034 as Precision Cancer Care Expands According to a report published by OG Analysis, the Companion Diagnostics Oncology Market is valued at USD 5.11 billion in 2026 and is projected to reach USD 12.31 billion by 2034, growing at a CAGR of 11.61%. Increasing biomarker-guided cancer treatment, targeted therapies and advanced...

The companion diagnostics market is becoming increasingly important as healthcare moves from broad treatment approaches toward precision medicine and biomarker-guided therapies. The market was valued at USD 9.6 billion in 2025 and is projected to grow from USD 10.3 billion in 2026 to USD 20.1 billion by 2033, registering a CAGR of 10.1% from 2026 to 2033. Increasing demand for precision...

The global molecular diagnostics market was valued at USD 18.8 billion in 2025. It is projected to reach USD 19.4 billion in 2026 and USD 25.6 billion by 2033, growing at a CAGR of 4.1% from 2026 to 2033, according to Grand View Research. North America led with a 44.1% revenue share in 2025. That growth is steady rather than explosive. Most of the value is concentrated in a few places:...

Polaris Market Research has published insightful research on US companion diagnostics (CDx) development Market. The research report offers an in-depth analysis of the market, covering all the major aspects, including market size, market share, growth drivers, and key trends. Besides, a thorough assessment of the annual forecast, strategies, and potential roadmaps has been provided in the...

The increasing adoption of precision healthcare approaches is transforming the diagnostics landscape through advanced biomarker testing, innovative companion diagnostic assays, and next-generation personalized medicine diagnostics. As pharmaceutical companies continue developing targeted therapies, the demand for diagnostic solutions that identify suitable patient populations has...

The global companion animal diagnostics market is entering a period of sustained expansion as pet ownership rises, veterinary healthcare spending increases, and pet owners become more focused on preventive care and early disease detection. The market size was valued at USD 7.1 billion in 2025 and is projected to grow from USD 7.8 billion in 2026 to USD 14.4 billion by 2033, registering a CAGR...

Market Overview The global veterinary diagnostics market size was valued at USD 7.96 billion in 2024, and it is estimated to reach from USD 8.7 billion in 2025 to USD 17.71 billion by 2033, growing at a CAGR of 9.3% during the forecast period (2025–2033). Factors such as increasing companion animals population and pet owners, significantly drives the...